These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7540829)

  • 1. Synthetic peptides representing sequences within gp41 of HIV as immunogens for murine T- and B-cell responses.
    Brown LE; White DO; Agius C; Kemp BE; Yatzakis N; Poumbourios P; McPhee DA; Jackson DC
    Arch Virol; 1995; 140(4):635-54. PubMed ID: 7540829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1.
    Bell SJ; Cooper DA; Kemp BE; Doherty RR; Penny R
    Clin Exp Immunol; 1992 Jan; 87(1):37-45. PubMed ID: 1370773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein.
    Haynes BF; Arthur LO; Frost P; Matthews TJ; Langlois AJ; Palker TJ; Hart MK; Scearce RM; Jones DM; McDanal C
    J Exp Med; 1993 Mar; 177(3):717-27. PubMed ID: 7679708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses.
    Estaquier J; Boutillon C; Georges B; Ameisen JC; Tartar A; Auriault C
    J Pept Sci; 1996; 2(3):165-75. PubMed ID: 9231325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic peptide to the E glycoprotein of Murray Valley encephalitis virus defines multiple virus-reactive T- and B-cell epitopes.
    Mathews JH; Roehrig JT; Brubaker JR; Hunt AR; Allan JE
    J Virol; 1992 Nov; 66(11):6555-62. PubMed ID: 1383567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of a self-assembling peptide derived from the envelope proteins of HIV type 1. An approach to heterovalent immunogens.
    Tripathy SP; Kumar A; Manivel V; Panda SK; Rao KV
    J Immunol; 1992 Jun; 148(12):4012-20. PubMed ID: 1534827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
    Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
    AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
    Neurath AR; Strick N; Lee ES
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus.
    McLain L; Durrani Z; Wisniewski LA; Porta C; Lomonossoff GP; Dimmock NJ
    Vaccine; 1996 Jun; 14(8):799-810. PubMed ID: 8817828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of antibody responses to breast carcinoma associated mucins using synthetic peptide constructs as immunogens.
    Denton G; Sekowski M; Price MR
    Cancer Lett; 1993 Jul; 70(3):143-50. PubMed ID: 7689035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients.
    Denner J; Norley S; Kurth R
    AIDS; 1994 Aug; 8(8):1063-72. PubMed ID: 7986401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of T-cell epitopes without B-cell activity in the first and second conserved regions of the HIV Env protein.
    Sastry KJ; Arlinghaus RB
    AIDS; 1991 Jun; 5(6):699-707. PubMed ID: 1715718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in the immunogenicity of HIV peptide antigens by chemical linkage to polytuftsin (TKPR40).
    Gokulan K; Khare S; Rao DN
    DNA Cell Biol; 1999 Aug; 18(8):623-30. PubMed ID: 10463058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the T-helper epitope on the titre and affinity of antibodies to B-cell epitopes after co-immunization.
    Shaw DM; Stanley CM; Partidos CD; Steward MW
    Mol Immunol; 1993 Aug; 30(11):961-8. PubMed ID: 7688851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonoverlapping T and B cell determinants on an hepatitis B surface antigen pre-S(2) region synthetic peptide.
    Milich DR; McLachlan A; Chisari FV; Thornton GB
    J Exp Med; 1986 Aug; 164(2):532-47. PubMed ID: 2425034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synthetic peptide from the first conserved region in the envelope protein gp160 is a strong T-cell epitope in HIV-infected chimpanzees and humans.
    Nehete PN; Schapiro SJ; Johnson PC; Murthy KK; Satterfield WC; Sastry KJ
    Viral Immunol; 1998; 11(3):147-58. PubMed ID: 9918406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
    Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chain.
    Zimmerman DH; Lloyd JP; Heisey D; Winship MD; Siwek M; Talor E; Sarin PS
    Vaccine; 2001 Sep; 19(32):4750-9. PubMed ID: 11535326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.